Toggle navigation
Home
Search
Services
Blog
Contact
About
Preclinical Efficacy and Intermediate Endpoints Assays
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Diurnal Variations in Salivary Concentrations of Pro-Tumorigenic Cytokines and Possible Effects of Psycho-Physiological Stress in Gynecologic Cancer Patients and Matched Healthy Controls
Osteoblast and Odontoblast Specific Regulatory Action of Runx2 for Bone and Tooth
Genetic Control of BB Rat Autoimmunity
HNF6 Function in the Pancreatic Endocrine Lineage
Std Faculty Expansion Program
Recently added grants:
Metabolic and Genetic Heterogeneity in Cancer
Coordinate Regulation of Oncogenic Signaling Pathways in SPOP Mutant Prostate Cancer
Integrin alpha6beta4 regulation of cancer epigenetics
Mechanisms of enhancer regulation in leukemia
Direct Small Molecule Activation of Pro-apoptotic BAK
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN43308-6-0-1
Application #
7587174
Study Section
Project Start
2004-05-15
Project End
2009-05-14
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Preclinical Efficacy and Intermediate Endpoints Assays
/ Washington University
$1,406,468
NIH 2007
N01 CA
Preclinical Efficacy and Intermediate Biomarker Assays
You, Ming /
$1,882,921
NIH 2007
N01 CA
Preclinical Efficacy and Intermediate Endpoints Assays
/
Comments
Be the first to comment on this grant